Form 4: KORU Medical Systems Director Edward Wholihan Acquires Additional Common Stock Under Pre-Planned Arrangement

Edward Wholihan, a Director at KORU Medical Systems, Inc., has acquired 4,189 shares of common stock at a price of $3.58 per share, executed under a Rule 10b5-1(c) plan.

Summary

• Edward Wholihan, a Director of KORU Medical Systems, Inc. (KRMD), acquired 4,189 shares of the company's common stock.
• The transaction occurred on July 2, 2025, at a price of $3.58 per share.
• This acquisition was made directly by Mr. Wholihan.
• Following this transaction, Mr. Wholihan beneficially owns a total of 37,772 shares of KORU Medical Systems common stock.
• The transaction was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged purchase.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even under a pre-planned Rule 10b5-1 arrangement, generally conveys a positive sentiment as it indicates management's confidence in the company's future.

Positives

• A Director's acquisition of additional shares typically signals confidence in the company's future prospects and valuation.
• The purchase increases the director's direct stake in the company, aligning their interests more closely with those of other shareholders.

Future Outlook

The document does not contain explicit forward-looking statements or guidance beyond the future transaction date.

Industry Context

Insider buying, even when pre-planned under a Rule 10b5-1 plan, is generally viewed by the market as a positive signal, indicating that a company's director believes the stock is undervalued or expects positive future performance. This aligns the director's financial interests with those of shareholders.

Related Party Transactions

• This Form 4 reports an insider transaction where a director of KORU Medical Systems, Inc. acquired shares of the company's common stock.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's belief in the company's value and future prospects, potentially increasing investor confidence.
• Employees and other stakeholders might interpret this as a sign of stability and positive internal outlook.

Key Dates

Recommendation

Keywords

KORU Medical Systems, KRMD, Form 4, insider transaction, director stock purchase, common stock, beneficial ownership, Rule 10b5-1